RESEARCH-USE BIOSIMILAR ANTIBODY

Namilumab

Monoclonal antibody · IgG1

CSF2IgG1RUO

Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis.

TARGETCSF2
YMonoclonal antibody
CATALOGSC-BS-351
CATALOG NUMBERSC-BS-351
MOLECULAR WEIGHTApprox. 145.78 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis.

Namilumab is a recombinant research-use antibody directed against CSF2.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte